Franklin Lakes, New Jersey

Unity Bank Loan Supports Mountain Lakes Veteran Low Income Housing Project

Retrieved on: 
Friday, June 9, 2023
Catholic Charities USA, Housing, Unity, Life, Loan, Veteran, Federal Home Loan Banks, Franklin Lakes, New Jersey, Congress, Acquisition, Bloomfield Avenue station, Newark-Pompton Turnpike, United States Congress, Principal, Catholic Church, Unity Bank of Canada, Real estate, Nouvelle

MOUNTAIN LAKES, N.J., June 09, 2023 (GLOBE NEWSWIRE) -- Unity Bank has provided a $350,000 commercial acquisition loan to Nouvelle, LLC of Franklin Lakes to help fund a four-unit disabled Veteran, low-income housing project at 367 Bloomfield Avenue, also known as 367 Route 46.

Key Points: 
  • MOUNTAIN LAKES, N.J., June 09, 2023 (GLOBE NEWSWIRE) -- Unity Bank has provided a $350,000 commercial acquisition loan to Nouvelle, LLC of Franklin Lakes to help fund a four-unit disabled Veteran, low-income housing project at 367 Bloomfield Avenue, also known as 367 Route 46.
  • Unity also sponsored Nouvelle for a $120,000 grant from the Federal Home Loan Bank of New York (FHLBNY) supporting the project.
  • “We are thankful for the support of Unity Bank and Commercial Loan Officer Vincent Forma for helping make this project a reality,” said Luciano Bruni, Principal of Nouvelle, LLC.
  • “The Mountain Lakes project is a great collaborative effort that will benefit Veterans in the community,” said Unity Bank President & CEO James A. Hughes.

Memorial Day Masses and Cardinal Dedication of New Chapel Mausoleum at Gate of Heaven Cemetery to Honor Veterans and Their Families

Retrieved on: 
Tuesday, May 16, 2023
Freedom, Friends, Flag Day, St George the Conqueror Chapel Mausoleum, The Resurrected Christ, Veteran, Franklin Lakes, New Jersey, Cemetery, Holy Name Cemetery (Jersey City, New Jersey), Gate, Memorial, Holy Cross Cemetery, Catholic Cemetery (Mobile, Alabama), Gate of Heaven Cemetery (Hawthorne, New York), Memorial Day, Courage, Family, Memory, Archbishop, Rain, Granite, Amusement park, Diocese

Our Memorial Day Masses honor the memory of fallen heroes, acknowledge the service of veterans and active-duty military personnel, and include prayers for all those interred in our cemeteries and mausoleums.

Key Points: 
  • Our Memorial Day Masses honor the memory of fallen heroes, acknowledge the service of veterans and active-duty military personnel, and include prayers for all those interred in our cemeteries and mausoleums.
  • The Archdiocese will also celebrate the dedication of the new Chapel Mausoleum of the Resurrection at Gate of Heaven Cemetery by His Eminence Cardinal Joseph W. Tobin, C.Ss.R., D.D., Archbishop of Newark.
  • *Gate of Heaven and Maryrest cemeteries will celebrate Memorial Day Mass inside their mausoleum chapels.
  • Catholic Cemeteries of the Archdiocese of Newark is committed to honoring and remembering veterans throughout the year during monthly Masses, Veteran's Day, Flag Day, and Memorial Day.

BD to Begin Remediation for BD Alaris™ System Software

Retrieved on: 
Thursday, July 29, 2021
Health, Food and Drug Administration, Life sciences, BD, Franklin Lakes, New Jersey, Federal Food, Drug, and Cosmetic Act, Alaris

FRANKLIN LAKES, N.J., July 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the company will begin remediation for the February 4, 2020 BD Alaris™ System1 recall through a new version of software.

Key Points: 
  • Effective today, customers can begin scheduling remediation by contacting the BD Recall Support Center at 1-888-562-6018.
  • In April 2021, BD announced that the company has submitted a 510(k) submission to the FDA for the BD Alaris System, which is intended to bring the regulatory clearance up to date.
  • This submission covers all modifications to the BD Alaris System since its last 510(k) clearance, including updated hardware features as well as software version 12.1.2.
  • This press release contains certain forward-looking statements regarding BD's 510(k) premarket notification to the FDA for the BD Alaris System.

BD To Announce Financial Results For Its Third Quarter Of Fiscal 2021

Retrieved on: 
Wednesday, June 30, 2021
Franklin Lakes, New Jersey, BD, New York Stock Exchange, Becton, Industry economics), Economic taxonomy, Companies

FRANKLIN LAKES, N.J., June 30, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the third quarter of fiscal year 2021 on Thursday, August 5, 2021.

Key Points: 
  • FRANKLIN LAKES, N.J., June 30, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its financial results for the third quarter of fiscal year 2021 on Thursday, August 5, 2021.
  • BD will issue a press release detailing the quarter's results, along with related presentation materials posted to www.bd.com/investors , at approximately 6:00 a.m. Eastern Time (ET).
  • ET on August 5, to discuss its financial results, an update on its operations, and its strategy.
  • BD also announced its plans to host an Investor Day on Friday, November 12, 2021.

BD Highlights Five-Year ESG Achievements in 2020 Sustainability Report, Setting the Foundation for 2030+ Strategy

Retrieved on: 
Tuesday, June 22, 2021
Articles, Ethics, BD, Franklin Lakes, New Jersey, Sustainability, Corporate social responsibility

"We have been consistently recognized for our leadership in corporate social responsibility and innovation," said Tom Polen, chairman, CEO and president, BD.

Key Points: 
  • "We have been consistently recognized for our leadership in corporate social responsibility and innovation," said Tom Polen, chairman, CEO and president, BD.
  • "These achievements in our 2020 focus areas form a strong foundation that we will build upon over the next decade.
  • Innovation: contributing to more sustainable health care systems by improving outcomes, reducing costs and protecting patients and health care workers.
  • Significant Achievements and Highlights from this year's report include:
    Innovation: Over the past five years, BD has evolved its portfolio through two transformational acquisitionsCareFusion in 2015 and C.R.

BD to Present at Upcoming Investor Conferences in June

Retrieved on: 
Wednesday, May 26, 2021
Microsoft, Companies, Software, BD, Franklin Lakes, New Jersey, Goldman Sachs, LinkedIn, Twitter

The Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, at 8:50 a.m. Eastern Time (ET).

Key Points: 
  • The Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, at 8:50 a.m. Eastern Time (ET).
  • Live webcasts of BD's presentations, along with any related materials, can be accessed on the BD corporate website at www.bd.com/investors .
  • By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
  • For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .

BD Leverages Artificial Intelligence To Transform Microbiology Urine Testing

Retrieved on: 
Wednesday, May 26, 2021
Academic disciplines, BD, Franklin Lakes, New Jersey, Laboratory equipment, Articles, Laboratory automation, Informatics, Science

Designed using artificial intelligence (AI) and leveraging the quality of BD BBL plated media, the application uses digital imaging and software algorithms to determine the amount of growth on a urine culture plate from clean caught and catheterized samples.

Key Points: 
  • Designed using artificial intelligence (AI) and leveraging the quality of BD BBL plated media, the application uses digital imaging and software algorithms to determine the amount of growth on a urine culture plate from clean caught and catheterized samples.
  • Powered by BD Synapsys informatics solution, the BD Kiestra Urine Culture application (UCA) may help improve lab efficiency and enhance quality by providing diagnostically relevant, standardized images for interpretation by laboratory staff.
  • The new Urine Culture app can be used with both standalone BD Kiestra ReadA systems as well as track-based BD Kiestra laboratory automation solutions.
  • BD Synapsys Informatics is the informatics platform for BD Integrated Diagnostic Solutions, including the BD Veritor Plus System and the BD MAX System, which have been granted Emergency Use Authorization by the U.S. Food and Drug Administration to perform SARS-CoV-2 diagnostic testing.

BD Launches Industry First Ready-to-Use Iodine-Based Surgical Irrigation System

Retrieved on: 
Tuesday, May 25, 2021
Albums, Compilation albums, Microsoft, BD, Franklin Lakes, New Jersey, Surgery, LinkedIn, Wound, Twitter, 1

BD Surgiphor is a pre-mixed, pre-labeled, single patient surgical wound irrigation solution.

Key Points: 
  • BD Surgiphor is a pre-mixed, pre-labeled, single patient surgical wound irrigation solution.
  • The introduction of BD Surgiphor will bring more simplicity to the sterile field and help meet best practices established by U.S. and global health agencies."
  • As we look ahead, we believe BD is well positioned to continue growing our presence in the surgical setting."
  • For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .

$12.13 Billion Disposable Syringes Market - Global Forecast to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 5, 2021
Pharmaceutical, Other Manufacturing, Medical Supplies, Health, Diabetes, Infectious diseases, Hospitals, Manufacturing, Medical equipment, Life sciences, Medicine, Biotechnology, Drug paraphernalia, BD, Franklin Lakes, New Jersey, Syringe, Fresenius, Injection, Safety syringe, Vaccine

b'The "Disposable Syringes Market Size, Trends & Analysis, By Product Type, By Application, By End Use, And By Region, Global Forecast To 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global disposable syringes market size is expected to reach USD 12.13 Billion in 2028, and register a CAGR of 5.3% during the forecast period.\nIncreasing prevalence of various chronic diseases, increasing use of botox injections, and high adoption of injectable drugs are key factors driving market revenue growth.\nHigh preference for administering injectable formulations among doctors in case of emergency or for quicker recovery of patients.\nMarket growth can be attributed to major factors such as growing geriatric population, preference for injections over drugs over faster recovery, development of technologically advanced syringes, and need for vaccination and immunization programs globally.\nAccording to estimations by WHO, approximately 16 Billion injections are administered every year globally.

Key Points: 
  • b'The "Disposable Syringes Market Size, Trends & Analysis, By Product Type, By Application, By End Use, And By Region, Global Forecast To 2028" report has been added to ResearchAndMarkets.com\'s offering.\nThe global disposable syringes market size is expected to reach USD 12.13 Billion in 2028, and register a CAGR of 5.3% during the forecast period.\nIncreasing prevalence of various chronic diseases, increasing use of botox injections, and high adoption of injectable drugs are key factors driving market revenue growth.\nHigh preference for administering injectable formulations among doctors in case of emergency or for quicker recovery of patients.\nMarket growth can be attributed to major factors such as growing geriatric population, preference for injections over drugs over faster recovery, development of technologically advanced syringes, and need for vaccination and immunization programs globally.\nAccording to estimations by WHO, approximately 16 Billion injections are administered every year globally.
  • This factual information, coupled with need for disposable syringes, that needs to be discarded after one use, to avoid spread of infectious diseases and cross contamination among patients are other major factors driving market growth.\nGrowing number of patient footfall in hospitals, and clinics, coupled with need for collecting blood samples for various tests are key factors expected to drive demand for disposable syringes from hospitals, clinics, and pathological laboratories.\nDisposable syringes are generally made of plastic, if these syringes are not disposed of properly, it can result in severe health issues because of pathogens present in these instruments.
  • These factors could hamper growth of the global disposable syringes market.\nSome Key Findings From the Report:\nAmong the product type segments, the safety syringes segment accounted for the largest revenue share in the global market in 2020, due to its safety features, thus eliminating the risks associated with it.\nAmong the application segments, the therapeutic injections segment accounted for the largest revenue share in the global disposable syringes market in 2020, due to use of disposable syringes for administering insulin to diabetic patients, high prevalence of infectious diseases such as HIV infection, malaria, etc.\nNorth America market accounted for the largest revenue share in the global disposable syringes market in 2020, growing prevalence of diabetes and other chronic diseases in countries in North America.\nThe Asia Pacific market is expected to register the highest revenue growth rate over the forecast period, owing to rapidly developing healthcare sector, increasing prevalence of diabetic population, and growing geriatric population resulting in need for disposable syringes to administer drugs.\nKey players profiled in the report include Braun Medical, Inc., Fresenius Kabi AG, Baxter International, Inc., Flextronics International Vita Needle Company, Terumo Corporation, Novo Nordisk, UltiMed, Inc., Henke-Sass, Wolf, Covidien, Retractable Technologies, Inc., and Becton Dickinson and Company.
  • The market players have adopted various strategies including mergers, acquisitions, partnerships, and new product developments, among other strategies, to stay ahead of the competition and expand market footprint.\nIn July 2020, Becton, Dickinson and Company partnered with the US government for Manufacturing Infrastructure Project for Mass Vaccination Campaigns worth USD 70 Million to support the US vaccination program for controlling spread of COVID-19.\n'

Elizabeth McCombs Appointed Chief Technology Officer at BD

Retrieved on: 
Wednesday, April 28, 2021
BD, Franklin Lakes, New Jersey, LinkedIn, Companies, Industry economics), Human resource management

"\nMcCombs, who brings more than 20 years of extensive experience in advanced medical device innovation to her new role, joined BD in 2019 as the senior vice president of R&D for the BD Medical Segment.

Key Points: 
  • "\nMcCombs, who brings more than 20 years of extensive experience in advanced medical device innovation to her new role, joined BD in 2019 as the senior vice president of R&D for the BD Medical Segment.
  • The SAB will meet to review BD\'s technology capabilities, innovation pipeline, tuck-in M&A opportunities and early-stage investments.
  • By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.
  • For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo .\n'